Literature DB >> 1626672

An evaluation of the Rapid Infusion System.

H U Rothen1, R Lauber, M Mosimann.   

Abstract

The performance of the Rapid Infusion System was evaluated in the laboratory. Using a conventional mixture of two units of packed red cells, two units of fresh frozen plasma and 500 ml crystalloid, a single line and a driving pressure of 300 mmHg, the highest flow in our study was 970 ml.min-1 (2.8 mm catheter, no stopcock). With a 1.6 mm venous cannula the measured flow was 640 ml.min-1. Additional diluting of the standard 'blood cocktail' did not add much to the performance of the system. When primed with tap water 21 degrees C (12 degrees C respectively), the fluid at the outlet of the system reached a maximum temperature of 37.8 degrees C (37.4 degrees C) after 6 min at a flow of 400 ml.min-1. At flows higher than 1150 ml.min-1 (priming with 12 degrees C tap water: 800 ml.min-1), the system slowed down to flows of 700 to 1000 ml.min-1 in order to maintain an adequate temperature. We conclude, that the Rapid Infusion System is a valuable tool for situations where a rapid but controlled replacement with warmed blood at rates up to at least 1100 ml.min-1 is needed. The use of large bore intravenous catheters and avoiding additional resistors such as standard 3-way stopcocks is highly recommended.

Entities:  

Mesh:

Year:  1992        PMID: 1626672     DOI: 10.1111/j.1365-2044.1992.tb02333.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  2 in total

1.  Factors affecting pediatric isotonic fluid resuscitation efficiency: a randomized controlled trial evaluating the impact of syringe size.

Authors:  Greg Harvey; Gary Foster; Asmaa Manan; Lehana Thabane; Melissa J Parker
Journal:  BMC Emerg Med       Date:  2013-07-24

2.  Study protocol for a randomised controlled trial comparing the efficiency of two provider-endorsed manual paediatric fluid resuscitation techniques.

Authors:  Evan T Cole; Greg Harvey; Gary Foster; Lehana Thabane; Melissa J Parker
Journal:  BMJ Open       Date:  2013-03-21       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.